Alkem Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Keep track of all breaking news and updates on Alkem Laboratories Ltd. from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

11 Feb 2025

4843.50

-0.51%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith the transcript of "Q3 FY2025 Earnings Conference Call" hosted by the Company on Friday, 07th February, 2025.

pdf

Alkem Laboratories Ltd.

10 Feb 2025

4843.50

-0.51%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held 13th February, 2025.

pdf

Alkem Laboratories Ltd.

08 Feb 2025

4843.50

-0.51%

Alkem Labs (SELL): Slower growth in a seasonally strong quarter

Sell: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Domestic sales were 6% below our estimates mainly due to slower recovery in the acute therapies and no price hike in NLEM portfolio

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.

Alkem Laboratories Ltd.

07 Feb 2025

4843.50

-0.51%

Alkem Labs announces acquisitions in skincare and medical devices segments

Business Line

To acquire 100% stake in Adroit Biomed, a pharmaceutical company focussed on the skincare segment, for around 140 crore

Alkem Laboratories L.. has an average target of 5278.50 from 2 brokers.

Alkem Laboratories Q3 net profit rises 5.2%, revenue sees marginal growth

Business Standard | 07 Feb 2025 1 more

Alkem Laboratories Ltd.

07 Feb 2025

4843.50

-0.51%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY25 Earnings Conference Call' is available on the website of the Company.

pdf

Alkem Laboratories Ltd.

07 Feb 2025

4843.50

-0.51%

Alkem Laboratories Results Earnings Call for Q3FY25

Conference Call with Alkem Laboratories Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Alkem Laboratories Ltd.

07 Feb 2025

4843.50

-0.51%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 and 47 read along with Schedule III of SEBI LODR Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) as notice to shareholders informing the record date fixed for the Interim Dividend for Financial Year 2024-2025, approved by the Board of Directors at its meeting held on Friday, 07th February, 2025. Kindly take note of the same.

pdf